Last reviewed · How we verify

diphenylcyclopropenone (DPCP) — Competitive Intelligence Brief

diphenylcyclopropenone (DPCP) (diphenylcyclopropenone (DPCP)) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Contact sensitizer / Immunostimulant. Area: Dermatology.

marketed Contact sensitizer / Immunostimulant Dermatology Small molecule Live · refreshed every 30 min

Target snapshot

diphenylcyclopropenone (DPCP) (diphenylcyclopropenone (DPCP)) — Ain Shams University. Diphenylcyclopropenone (DPCP) is a contact sensitizer that triggers a delayed-type hypersensitivity reaction to stimulate immune-mediated hair growth in alopecia.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
diphenylcyclopropenone (DPCP) TARGET diphenylcyclopropenone (DPCP) Ain Shams University marketed Contact sensitizer / Immunostimulant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Contact sensitizer / Immunostimulant class)

  1. Ain Shams University · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). diphenylcyclopropenone (DPCP) — Competitive Intelligence Brief. https://druglandscape.com/ci/diphenylcyclopropenone-dpcp. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators: